Michael J Buege (Michael Buege)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

The Annals of pharmacotherapy

European journal of haematology

Leukemia & lymphoma

Blood advances

Memorial Sloan Kettering Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan Kettering Cancer Center Aug 20 2018

United States

Clinical Pharmacy Specialist :: Clinical coordinators

Publications

David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha H Merrill, Priyanka Pullarkat, Richard C Godby, David A Bond, Graham T Wehmeyer, Jason T Romancik, Behzad Amoozgar, Lori A Leslie, Loretta J Nastoupil, Jennifer L Crombie, Jeremy S Abramson, Arushi Khurana, Grzegorz S Nowakowski, Kami J Maddocks, Sarah C Rutherford, Brad S Kahl, Michelle Okwali, Michael J Buege, Venkatraman E Seshan, Connie Lee Batlevi, Gilles Andre Salles
Tafasitamab and lenalidomide in large B cell lymphoma: real-world outcomes in a multicenter retrospective study. Blood (2023)
Michael J Buege, Esther Drill, Steven M Horwitz, Andréa LeVoir, Terry Pak, Tim J Peterson, Phuong H Dao, Matthew J Matasar
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure. European journal of haematology (2023)
Michael J Buege, Esther Drill, Steven M Horwitz, Andréa LeVoir, Terry Pak, Tim J Peterson, Phuong H Dao, Matthew J Matasar
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure. European journal of haematology (2023)
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, Jason T Romancik, Manali Kamdar, Irl Brian Greenwell, Brian T Hess, Krista M Isaac, Craig A Portell, Alex V Mejia Garcia, Scott R Goldsmith, Natalie S Grover, Peter A Riedell, Reem Karmali, Madelyn Burkart, Michael J Buege, Othman S Akhtar, Pallawi Torka, Anita Kumar, Brian T Hill, Brad S Kahl, Jonathon B Cohen
A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma. Blood advances (2023)
Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss, Krisoula H Spatz, Andrea C Levoir, Terry K Pak, Phuong H Dao, Michael J Buege, Lauren M Derespiris, Carmen Lau, Jennifer S Orozco, Manpreet Boparai, Lauren A Koranteng, Kate E Reichert, Shirley Q Yan, Nicole P Daukshus, Sherry Mathew, Larry W Buie, Richard F Tizon, Scott Freeswick, Dazhi Liu, Stephen Harnicar
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (2) (2021)
Terry K Pak, Brianne N Dixon, Michael J Buege, Phuong H Dao, Megan H Leary, Joy C Jarrett, Tara A Duggan, Philip Caron, Lorenzo Falchi, Paul Hamlin, Audrey Hamilton, Matthew J Matasar, Alison Moskowitz, Ariela Noy, Colette N Owens, Gottfried Von Keudell, Anas Younes, Andrew D Zelenetz, Anita Kumar
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience. Leukemia & lymphoma (2021)
Michael J Buege, Anita Kumar, Brianne N Dixon, Laura A Tang, Terry Pak, Jennifer Orozco, Tim J Peterson, Kathryn T Maples
Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents. The Annals of pharmacotherapy 54 (9) (2020)
Tim J Peterson, Jennifer Orozco, Michael J Buege
Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma. The Annals of pharmacotherapy 54 (6) (2019)

Michael J Buege.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Buege)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Buege (Michael Buege)